COVIDCapture Technology
Proven capability to eliminate 99.9% of the SARS-CoV-2
virus from the air in independent laboratory testing
virus from the air in independent laboratory testing
The Defender's "COVID Capture Technology" has been independently
tested to eliminate and destroy the SARS-CoV-2 virus.
tested to eliminate and destroy the SARS-CoV-2 virus.
“COVID Capture Technology” means that the Defender has been independently tested and found to eliminate 99.9% of SARS-CoV
-2 in a real-world setting (1,000 cubic foot space) within 90 minutes. Additional testing of the viability of the captured pathogen
found that at least 95% of the captured pathogen in the filter was no longer viable after just the first 24 hours. The test utilized the
CDC recommended MS2 Bacteriophage testing meeting the capture requirements set by the FDA Guidelines.”
Proven capability to eliminate 99.9%
within 90 minutes and destroy over 95%
within 24 hours.
99.9% reduction in 90 minutes. 95% destroyed within 24
hours. See the efficacy study summary in its entirety.
Download the study here.
Independently tested by a University
Hospital Infection Control Team
Conclusion from a hospital testing the FilterQueen
Defender air purifier (FQD):
"Despite its compactness and significantly lower price (80% less as
compared to standard mobile HEPA filters), the FQD has shown to be
highly effective in purifying air, as expressed by the lower particle
count and absence of fungal spores within 1 hour. Based upon this
experience, we decided to purchase multiple FQD devices that are
now routinely used throughout the hospital in high-risk settings, such
as during construction works or to prevent airborne infection in
isolation rooms."
Used by doctors to mitigate the risk
associated with aerosolized infections
From waiting rooms, the crowded lobbies, to patient
rooms, medical professionals are using the Defender
air purifier to help. See what doctors are saying:
"With the amount of patient traffic and doctors we have in our clinic,
I've gone ahead and put the Defender in each of our three office
locations to try to mitigate the risk associated with aerosolized
infections."
–MK Batra, MD
–MK Batra, MD